The goal of most microarray experiments is to survey patterns of gene expression by assaying the expression levels of thousands to tens of thousands of genes in a single assay. Typically, RNA is first ...

DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...

A six-year-old boy from Sussex has become one of only about 75 people worldwide to be diagnosed with an ultra-rare genetic ...

The use of microarrays to analyse gene expression on a global level has recently received a great deal of attention. There has been much speculation about the power of this approach in the analysis of ...

BioForge and Panther Life Sciences explain how their partnership is advancing vaccine patch technology and keeping the ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe ...

As genetic testing becomes increasingly important in modern healthcare, cytogenetics is emerging as a promising career for ...

The SureScan Microarray Scanner is a key component of Agilent’s complete microarray solution. With improved feature resolution, it delivers exceptional flexibility to analyze any microarray ...

According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...